• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5,813
2,295
2,200
2,085
1,933

COUNTRY

1,075
851
272
244
224

CATEGORIES

  • 929
  • 169
  • 112
  • 287
    • 49
  • 473
  • 228
  • 237
  • 53
  • 63
  • 809
  • 1,438
  • 820
  • 18
  • 448
  • 1,382
  • 2,301
    • 82
    • 120
    • 66
    • 66
    • 36
    • 37
    • 11
    • 11
    • 12
    • 18
  • 23
  • 264
  • 39

PRICE

5,783
12,916
21,237
26,439

PUBLISHED

4,142
4,910
10,433
26,439

PRODUCT TYPE

21,815
2,394
1,022
934
164
45
21
19
14
6
4
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Contraception-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Contraception-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Contraception-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Contraception-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Contraception....

February 2015
FROM
Contact Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Contact Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Contact Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Contact Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Contact...

February 2015
FROM
Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Complex Partial Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Complex Partial Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Complex Partial Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Complex Partial Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Complex...

February 2015
FROM
Community-Acquired Bacterial Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Community-Acquired Bacterial Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Community-Acquired Bacterial Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Community-Acquired Bacterial Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs...

February 2015
FROM
Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Colorectal...

February 2015
FROM
Type 1 Diabetes (Juvenile Diabetes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Type 1 Diabetes (Juvenile Diabetes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Type 1 Diabetes (Juvenile Diabetes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Type 1 Diabetes (Juvenile Diabetes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs...

February 2015
FROM
Tuberculous Meningitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Tuberculous Meningitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Tuberculous Meningitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Tuberculous Meningitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Tuberculous...

February 2015
FROM
Tuberculosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Tuberculosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Tuberculosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Tuberculosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Tuberculosis....

February 2015
FROM
Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Transplantation....

February 2015
FROM
Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Tonsillitis....

February 2015
FROM
Tinea Versicolor (Cutaneous Mycoses)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Tinea Versicolor (Cutaneous Mycoses)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Tinea Versicolor (Cutaneous Mycoses)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Tinea Versicolor (Cutaneous Mycoses)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs...

February 2015
FROM
Tinea Cruris (Jock Itch)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Tinea Cruris (Jock Itch)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Tinea Cruris (Jock Itch)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Tinea Cruris (Jock Itch)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Tinea Corporis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Tinea Corporis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Tinea Corporis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Tinea Corporis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Tinea Corporis....

February 2015
FROM
Poisoning-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Poisoning-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Poisoning-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Poisoning-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Poisoning. A key...

February 2015
FROM
Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Pneumonia. A key...

February 2015
FROM
Plaque Psoriasis (Psoriasis Vulgaris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Plaque Psoriasis (Psoriasis Vulgaris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Plaque Psoriasis (Psoriasis Vulgaris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs...

February 2015
FROM
Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Pharyngitis....

February 2015
FROM
Parkinson's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Parkinson's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Parkinson's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Parkinson's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Parkinson's...

February 2015
FROM
Paget's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Paget's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Paget's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Paget's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Paget's Disease....

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S